These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24156136)

  • 1. A clinical investigation using quantitative light-induced fluorescence (QLF) of the anticaries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate.
    Yin W; Hu DY; Fan X; Feng Y; Zhang YP; Cummins D; Mateo LR; Pretty IA; Ellwood RP
    J Clin Dent; 2013; 24 Spec no A():A15-22. PubMed ID: 24156136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-caries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate assessed using Quantitative Light-induced Fluorescence (QLF).
    Yin W; Hu DY; Li X; Fan X; Zhang YP; Pretty IA; Mateo LR; Cummins D; Ellwood RP
    J Dent; 2013 Aug; 41 Suppl 2():S22-8. PubMed ID: 23985435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical investigation of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride, as sodium monofluorophosphate in a calcium base, on primary root caries.
    Hu DY; Yin W; Li X; Feng Y; Zhang YP; Cummins D; Mateo LR; Ellwood RP
    J Clin Dent; 2013; 24 Spec no A():A23-31. PubMed ID: 24156137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of early coronal caries as assessed using Quantitative Light-induced Fluorescence.
    Srisilapanan P; Korwanich N; Yin W; Chuensuwonkul C; Mateo LR; Zhang YP; Cummins D; Ellwood RP
    J Dent; 2013 Aug; 41 Suppl 2():S29-34. PubMed ID: 23985436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of the efficacy of dentifrices containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride over two years.
    Li X; Zhong Y; Jiang X; Hu Deyu ; Mateo LR; Morrison BM; Zhang YP
    J Clin Dent; 2015; 26(1):7-12. PubMed ID: 26054185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ clinical effects of new dentifrices containing 1.5% arginine and fluoride on enamel de- and remineralization and plaque metabolism.
    Cantore R; Petrou I; Lavender S; Santarpia P; Liu Z; Gittins E; Vandeven M; Cummins D; Sullivan R; Utgikar N
    J Clin Dent; 2013; 24 Spec no A():A32-44. PubMed ID: 24156138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of primary root caries.
    Souza ML; Cury JA; Tenuta LM; Zhang YP; Mateo LR; Cummins D; Ellwood RP
    J Dent; 2013 Aug; 41 Suppl 2():S35-41. PubMed ID: 23985437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical investigation of the anticaries efficacy of a 1.14% sodium monofluorophosphate (SMFP) calcium carbonate-based dentifrice: a two-year caries clinical trial on children in China.
    Fan X; Li X; Wan H; Hu D; Zhang YP; Volpe AR; DeVizio W
    J Clin Dent; 2008; 19(4):134-7. PubMed ID: 19278083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year caries clinical study of the efficacy of novel dentifrices containing 1.5% arginine, an insoluble calcium compound and 1,450 ppm fluoride.
    Kraivaphan P; Amornchat C; Triratana T; Mateo LR; Ellwood R; Cummins D; DeVizio W; Zhang YP
    Caries Res; 2013; 47(6):582-90. PubMed ID: 23988908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative anticaries efficacy of sodium fluoride and sodium monofluorophosphate dentifrices. A two-year caries clinical trial on children in New Jersey and Puerto Rico.
    Saporito RA; Boneta AR; Feldman CA; Cinotti W; Sintes JL; Stewart B; Volpe AR; Proskin HM
    Am J Dent; 2000 Aug; 13(4):221-6. PubMed ID: 11763937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a dentifrice containing 8% arginine, calcium carbonate, and sodium monofluorophosphate to prevent enamel loss after erosive challenges using an intra-oral erosion model.
    Sullivan R; Rege A; Corby P; Klaczany G; Allen K; Hershkowitz D; Godder B; Wolff M
    J Clin Dent; 2014; 25(1 Spec No A):A7-13. PubMed ID: 24933798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of a new dentifrice containing 1.5% arginine and 1450 ppm fluoride on plaque metabolism.
    Wolff M; Corby P; Klaczany G; Santarpia P; Lavender S; Gittins E; Vandeven M; Cummins D; Sullivan R
    J Clin Dent; 2013; 24 Spec no A():A45-54. PubMed ID: 24156139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative anticaries effectiveness of sodium monofluorophosphate and sodium fluoride as contained in currently available dentifrice formulations.
    DePaola PF; Soparkar PM; Triol C; Volpe AR; Garcia L; Duffy J; Vaughan B
    Am J Dent; 1993 Sep; 6 Spec No():S7-12. PubMed ID: 7488359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
    Schiff T; Mateo LR; Delgado E; Cummins D; Zhang YP; DeVizio W
    J Clin Dent; 2011; 22(4):128-38. PubMed ID: 22403989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-week clinical study assessing the clinical effects on plaque metabolism of a dentifrice containing 1.5% arginine, an insoluble calcium compound and 1,450 ppm fluoride.
    Santarpia RP; Lavender S; Gittins E; Vandeven M; Cummins D; Sullivan R
    Am J Dent; 2014 Apr; 27(2):100-5. PubMed ID: 25000668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.
    Hughes N; Mason S; Jeffery P; Welton H; Tobin M; O'Shea C; Browne M
    J Clin Dent; 2010; 21(2):49-55. PubMed ID: 20669816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Lasting Efficacy of an Experimental 1450 ppm Fluoride/Zinc-Based Dentifrice as Measured by Calcium Buildup Using an In Situ Intra-Oral Device After 12 Hours: A Randomized Clinical Trial.
    Richter R; Jogun S; Won B; Zhang YP; Miller S
    J Clin Dent; 2015; 26(4):91-5. PubMed ID: 26856014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Established Gingivitis and Dental Plaque Using a 1450 ppm Fluoride/Zinc-based Dentifrice: A Randomized Clinical Study.
    Zhong Y; Li X; Hu DY; Mateo LR; Morrison BM; Delgado E; Zhang YP
    J Clin Dent; 2015; 26(4):104-8. PubMed ID: 26856016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of autofluorescence to detect the remineralization capabilities of sodium fluoride, monofluorophosphate and non-fluoride dentifrices. A single-blind cluster randomized trial.
    Feng Y; Yin W; Hu D; Zhang YP; Ellwood RP; Pretty IA
    Caries Res; 2007; 41(5):358-64. PubMed ID: 17713335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative anticaries efficacy of a dentifrice containing 0.3% triclosan and 2.0% copolymer in a 0.243% sodium fluoride/silica base and a dentifrice containing 0.243% sodium fluoride/silica base: a two-year coronal caries clinical trial on adults in Israel.
    Mann J; Vered Y; Babayof I; Sintes J; Petrone ME; Volpe AR; Stewart B; De Vizio W; McCool JJ; Proskin HM
    J Clin Dent; 2001; 12(3):71-6. PubMed ID: 11505964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.